IceCure Medical to Report Third Quarter 2025 Financial and Operating Results on November 19, 2025

Accessibility StatementSkip Navigation CAESAREA, Israel, Nov. 12, 2025 /PRNewswire/ --Â IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that it will issue a press release with its financial and operational results as of and for the nine months ended September 30, 2025 before the Nasdaq Stock Market opens on Wednesday, November 1 ...